SCHEMBL606996

SCHEMBL606996

Nc1ccccc1-c1ccccc1-c1ccccc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.80
HSD17B10 Q99714 3/20 0.80
L3MBTL1 Q9Y468 1/20 0.68
SMN1; SMN2 Q16637 2/20 0.52
HPGD P15428 2/20 0.52
KDM4E B2RXH2 1/20 0.52
NPC1 O15118 1/20 0.52
GAA P10253 1/20 0.52
RAB9A P51151 1/20 0.52
SMARCA2 P51531 2/20 0.46
SMARCA4 P51532 2/20 0.46
PBRM1 Q86U86 2/20 0.46
ADORA3 P0DMS8 1/20 0.46
BRD4 O60885 1/20 0.46
NR1I2 O75469 1/20 0.46
CYP3A4 P08684 2/20 0.45
ALOX15 P16050 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
DPP4 P27487 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29607177 1.00 ALDH1A1 (0.80) ALDH1A1HSD17B10L3MBTL1SMN1; SMN2HPGD
SCHEMBL29413803 1.00 ALDH1A1 (0.80) ALDH1A1HSD17B10L3MBTL1SMN1; SMN2HPGD
SCHEMBL845163 1.00 ALDH1A1 (0.80) ALDH1A1HSD17B10L3MBTL1SMN1; SMN2HPGD
Ammonia Solution, Strong SCHEMBL28907116 0.97 ALDH1A1 (0.76) ALDH1A1HSD17B10L3MBTL1SMN1; SMN2HPGD
SCHEMBL27966482 0.95 ALDH1A1 (0.73) ALDH1A1HSD17B10L3MBTL1SMN1; SMN2HPGD
SCHEMBL21495966 0.95 ALDH1A1 (0.73) ALDH1A1HSD17B10L3MBTL1SMN1; SMN2HPGD
SCHEMBL17709515 0.91 ALDH1A1 (0.67) ALDH1A1HSD17B10L3MBTL1SMN1; SMN2HPGD
SCHEMBL29407079 0.89 ALDH1A1 (1.00) ALDH1A1HSD17B10L3MBTL1SMN1; SMN2HPGD
SCHEMBL25981 0.89 ALDH1A1 (1.00) ALDH1A1HSD17B10L3MBTL1SMN1; SMN2HPGD
SCHEMBL28465796 0.89 ALDH1A1 (1.00) ALDH1A1HSD17B10L3MBTL1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 865 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119798696-A Preparation method of bionic parallel vein-shaped two-dimensional supermolecular layer 西北工业大学 2025-04-11 CN claimed
CN-113788783-B Self-reporting photosensitizer and preparation method and application thereof 江南大学 2023-08-22 CN claimed
US-20230123529-A1 METHOD OF TUNING THE ELECTRONIC ENERGY LEVEL OF COVALENT ORGANIC FRAMEWORK FOR CRAFTING HIGH-RATE NA-ION BATTERY ANODE INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) 2023-04-20 US claimed
WO-2021198868-A1 METHOD OF TUNING THE ELECTRONIC ENERGY LEVEL OF COVALENT ORGANIC FRAMEWORK FOR CRAFTING HIGH-RATE NA-ION BATTERY ANODE INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) 2021-10-07 WO claimed
EP-3351523-B1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME LG CHEMICAL LTD (KR) 2020-11-04 EP claimed
US-10651411-B2 Compound and organic light emitting device containing same LG CHEM, LTD. (KR) 2020-05-12 US claimed
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2019-09-24 US claimed
CN-106226378-B One kind is embedded with fluoropolymer-containing nitrogen dioxide sensor and preparation method thereof 电子科技大学 2019-03-12 CN claimed
EP-3351523-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME LG Chem, Ltd. (KR) 2018-07-25 EP claimed
EP-3351531-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG Chem, Ltd. (KR) 2018-07-25 EP claimed
US-20180145272-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME LG CHEM, LTD. (KR) 2018-05-24 US claimed
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-08 US claimed
CN-100346232-C Photoconductor for electrophotography LEXMARK INT INC (US) 2007-10-31 CN claimed
WO-2005035121-A2 SCHIFF BASE METAL COMPLEXES FOR USE AS CATALYSTS IN ORGANIC SYNTHESIS UNIVERSITEIT GENT (BE) 2005-04-21 WO claimed
CN-1328658-A Photoconductor for electrophotography LEXMARK INT INC (US) 2001-12-26 CN claimed
JP-6080661-A None JP disclosed
US-20260143900-A1 HETEROCYCLIC COMPOUND, COMPOSITION FOR ORGANIC LAYER INCLUDING THE SAME, AND LIGHT EMITTING DEVICE INCLUDING THE SAME LT MAT CO LTD (KR) 2026-05-21 US disclosed
US-5578697-A DIELECTRIC POLYMERS FOR ELECTRONICS KABUSHIKI KAISHA TOSHIBA (JP) 1996-11-26 US disclosed
JP-H0680661-A TRIOXANE DERIVATIVE AND CHEMILUMINESCENCE NIPPON OIL & FATS CO LTD 1994-03-22 JP disclosed
US-4985156-A ALPHA-OLEFIN OLIGOMER MODIFIED BY MALEIC ANHYDRIDE, SECONDARY AMINE, ALKANOLAMINE, BORIC ACID, FOR LUBRICANTS MOBIL OIL CORPORATION (US) 1991-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260143900-A1 HETEROCYCLIC COMPOUND, COMPOSITION FOR ORGANIC LAYER INCLUDING THE SAME, AND LIGHT EMITTING DEVICE INCLUDING THE SAME PTGER1, OXER1, CBR1 ALDH1A1 1496/4885HSD17B10 1024/4885L3MBTL1 4235/4885
US-20180145272-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME CRY1, CRY2, OR10J3 ALDH1A1 87/4885HSD17B10 2296/4885L3MBTL1 349/4885
US-10651411-B2 Compound and organic light emitting device containing same CRY1, CRY2, OR10J3 ALDH1A1 87/4885HSD17B10 2296/4885L3MBTL1 349/4885
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, CRY2, PER2 ALDH1A1 486/4885HSD17B10 2413/4885L3MBTL1 856/4885
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, PER2 ALDH1A1 486/4885HSD17B10 2413/4885L3MBTL1 856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.